LSL Pharma Group, Inc. (LSL.V)
0.30
0.00 (0.00%)
CAD |
TSXV |
Oct 08, 16:00
LSL Pharma Group Gross Profit Margin (Quarterly) : 8.95% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.95% |
| March 31, 2026 | 5.57% |
| December 31, 2025 | -22.28% |
| September 30, 2025 | 28.89% |
| June 30, 2025 | 25.37% |
| March 31, 2025 | 31.26% |
| December 31, 2024 | 25.83% |
| Date | Value |
|---|---|
| September 30, 2024 | 28.91% |
| June 30, 2024 | 35.86% |
| March 31, 2024 | 26.71% |
| December 31, 2023 | 1.88% |
| September 30, 2023 | 17.24% |
| June 30, 2023 | 32.35% |
| March 31, 2023 | 17.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vitality Products, Inc. | 74.34% |
| Genix Pharmaceuticals Corp. | -- |
| Leef Brands, Inc. | -1.32% |
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 41.65% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.84% |
| Return on Assets | -10.08% |
| Return on Invested Capital | -11.73% |
| Profit Margin (Quarterly) | -15.33% |
| Operating Margin (Quarterly) | -7.53% |
| Return on Net Operating Assets | -10.59% |